Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 1591 AL 1605

Parkinson's disease, anxious depression and serotonin--zooming in on hippocampal neurogenesis

Blum R, Lesch KP.

J Neurochem. 2015 Nov;135(3):441-4. doi: 10.1111/jnc.13278. Epub 2015 Sep 17.

Comparison of the accuracy of three algorithms in predicting accessory pathways among adult Wolff-Parkinson-White syndrome patients

Maden O, Balci KG, Selcuk MT, Balci MM, Açar B, Unal S, Kara M, Selcuk H.

J Interv Card Electrophysiol. 2015 Dec;44(3):213-9. doi: 10.1007/s10840-015-0057-6. Epub 2015 Sep 18.

Initial drug treatment in Parkinson's disease

Muzerengi S, Clarke CE.

BMJ. 2015 Sep 18;351:h4669. doi: 10.1136/bmj.h4669.

A systematic review on the applications of resting-state fMRI in Parkinson's disease: Does dopamine replacement therapy play a role?

Tahmasian M, Bettray LM, van Eimeren T, Drzezga A, Timmermann L, Eickhoff CR, Eickhoff SB, Eggers C.

Cortex. 2015 Dec;73:80-105. doi: 10.1016/j.cortex.2015.08.005. Epub 2015 Aug 14.

Beta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer's Disease

Korsak M, Kozyreva T.

Adv Exp Med Biol. 2015;870:401-21. doi: 10.1007/978-3-319-20164-1_14.

Different patterns of spontaneous brain activity between tremor-dominant and postural instability/gait difficulty subtypes of Parkinson's disease: a resting-state fMRI study

Chen HM, Wang ZJ, Fang JP, Gao LY, Ma LY, Wu T, Hou YN, Zhang JR, Feng T.

CNS Neurosci Ther. 2015 Oct;21(10):855-66. doi: 10.1111/cns.12464.

Oscillations in pedunculopontine nucleus in Parkinson's disease and its relationship with deep brain stimulation

Li M, Zhang W.

Front Neural Circuits. 2015 Sep 2;9:47. doi: 10.3389/fncir.2015.00047. eCollection 2015.

Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia

Benussi A, Padovani A, Borroni B.

Front Aging Neurosci. 2015 Sep 1;7:171. doi: 10.3389/fnagi.2015.00171. eCollection 2015.

Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases

Wootla B, Watzlawik JO, Warrington AE, Wittenberg NJ, Denic A, Xu X, Jordan LR, Papke LM, Zoecklein LJ, Pierce ML, Oh SH, Kantarci OH, Rodriguez M.

JAMA Neurol. 2015 Nov;72(11):1346-53. doi: 10.1001/jamaneurol.2015.2188.

Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease

Bhidayasiri R, Hattori N, Jeon B, Chen RS, Lee MK, Bajwa JA, Mok VC, Zhang B, Syamsudin T, Tan LC, Jamora RD, Pisarnpong A, Poewe W.

Expert Rev Neurother. 2015;15(11):1285-97. doi: 10.1586/14737175.2015.1088783. Epub 2015 Sep 21.

Gait Pattern and Cognitive Performance During Treadmill Walking in Parkinson Disease

Fernández-Lago H, Bello O, López-Alonso V, Sánchez JA, Morenilla L, Fernández-del-Olmo MÁ.

Am J Phys Med Rehabil. 2015 Nov;94(11):931-40. doi: 10.1097/PHM.0000000000000392.

Clinical efficacy of istradefylline versus rTMS on Parkinson's disease in a randomized clinical trial

Li ZJ, Wu Q, Yi CJ.

Curr Med Res Opin. 2015 Nov;31(11):2055-8. doi: 10.1185/03007995.2015.1086994. Epub 2015 Sep 22.

Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells

Pantcheva P, Reyes S, Hoover J, Kaelber S, Borlongan CV.

Expert Rev Neurother. 2015 Oct;15(10):1231-40. doi: 10.1586/14737175.2015.1091727. Epub 2015 Sep 22.

When rejuvenation is a problem: challenges of modeling late-onset neurodegenerative disease

Vera E, Studer L.

Development. 2015 Sep 15;142(18):3085-9. doi: 10.1242/dev.120667.

Light pigmentation phenotype is correlated with increased substantia nigra echogenicity

Rumpf JJ, Schirmer M, Fricke C, Weise D, Wagner JA, Simon J, Classen J.

Mov Disord. 2015 Nov;30(13):1848-52. doi: 10.1002/mds.26427. Epub 2015 Sep 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias